Inventor · disambiguated record
Romain Siegrist
Also filed as: SIEGRIST ROMAIN
16 granted patents·9 pending applications·35 citations·filing 2006–2021
90Inventor score
Top patents by PatentIndex Score
25 records- 0185US10065929B2Pyrazole compounds and their use as T-type calcium channel blockersIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Sep 4, 2018·5 cites·30 claims
- 0284US9932314B2Pyrazole compounds and their use as T-type calcium channel blockersIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Apr 3, 2018·5 cites·28 claims
- 0382US10246426B2Triazole compounds as T-type calcium channel blockersIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Apr 2, 2019·5 cites·13 claims
- 0480US8697869B23-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2011·Granted Apr 15, 2014·6 cites·25 claims
- 0576US9879006B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Jan 30, 2018·2 cites·29 claims
- 0675US9096595B27-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2012·Granted Aug 4, 2015·4 cites·18 claims
- 0772US8889688B2Piperazines as antimalarial agentsAISSAOUI HAMED·Filed 2011·Granted Nov 18, 2014·2 cites·36 claims
- 0870US8575158B21-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2011·Granted Nov 5, 2013·2 cites·16 claims
- 0969US7902196B2Synthesis of avrainvillamide, strephacidin B, and analogues thereofHARVARD COLLEGE·Filed 2006·Granted Mar 8, 2011·2 cites·69 claims
- 1067US8329706B2Oxazolidinone derivativesAISSAOUI HAMED·Filed 2010·Granted Dec 11, 2012·1 cites·15 claims
- 1166US9850241B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Dec 26, 2017·1 cites·12 claims
- 1257US2023303486A1Cyclobutyl-urea derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1355US2023136562A1Spirourea derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1455US2011105514A15,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compoundsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 1554US10301309B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted May 28, 2019·0 cites·14 claims
- 1654US2011105491A1Thiazolidine compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 1752US2011086889A1Tetrazole compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 1852US2011212968A1Phenethylamide derivatives and their heterocyclic analoguesAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 1950US10351560B2Crystalline formsIDORSIA PHARMACEUTICALS LTD·Filed 2016·Granted Jul 16, 2019·0 cites·13 claims
- 2046US2011105515A1Targeting the oncoprotein nucleophosminHARVARD COLLEGE·Filed 2008·Application pending·0 cites
- 2144US9169270B21-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Oct 27, 2015·0 cites·17 claims
- 2243US9255090B2Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsACTELION PHARMACEUTICALS LTD·Filed 2012·Granted Feb 9, 2016·0 cites·20 claims
- 2340US9637473B2Acrylamide derivatives as antimalarial agentsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted May 2, 2017·0 cites·14 claims
- 2438US2011166170A1Synthesis of avrainvillamide, stephacidin b, and analogues thereofHARVARD COLLEGE·Filed 2010·Application pending·0 cites
- 2536US2012088759A1Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Romain Siegrist files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →